NCT07564817

Brief Summary

This study evaluates the effects of the Speed Sleep supplement on sleep quality and quantity in adults aged 18-65 years. Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed using Fitbit sleep tracking data and questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2025

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 27, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 27, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

Sleep qualitySleep latencyInsomnia symptoms

Outcome Measures

Primary Outcomes (7)

  • Change in Sleep Score

    Assessed using Fitbit-generated sleep score reflecting overall sleep quality. Higher scores indicate better sleep quality.

    Baseline and Week 4

  • Change in Total Sleep Time

    Measured using Fitbit as total time asleep during the night.

    Baseline and Week 4

  • Change in Time Awake During Sleep Period

    Measured using Fitbit as total time awake during the sleep period.

    Baseline and Week 4

  • Change in Number of Awakenings

    Measured using Fitbit as number of awakenings during the sleep period.

    Baseline and Week 4

  • Change in Deep Sleep Duration

    Measured using Fitbit as time spent in deep sleep stages.

    Baseline and Week 4

  • Change in REM Sleep Duration

    Measured using Fitbit as time spent in REM sleep stages.

    Baseline and Week 4

  • Change in Sleep Quality Score (SQS)

    Assessed using the validated Sleep Quality Score (SQS) questionnaire. Scores reflect subjective sleep quality, with changes over time indicating improvement or decline.

    Baseline, Week 1, Week 2, Week 3, Week 4

Secondary Outcomes (3)

  • Change in Sleep Latency

    Baseline, Week 1, Week 2, Week 3, Week 4

  • Change in Self-Reported Anxiety Levels

    Baseline, Week 1, Week 2, Week 3, Week 4

  • Change in Self-Reported Level of Relaxation

    Baseline, Week 1, Week 2, Week 3, Week 4

Study Arms (2)

Speed Sleep Supplement

EXPERIMENTAL

Participants receive Speed Sleep supplement daily for 4 weeks.

Dietary Supplement: Dietary Supplement: Speed Sleep

Placebo

PLACEBO COMPARATOR

Participants receive placebo capsules daily for 4 weeks.

Dietary Supplement: Placebo

Interventions

Six capsules taken once daily 30 minutes before bedtime.

Speed Sleep Supplement
PlaceboDIETARY_SUPPLEMENT

Six rice flour capsules taken once daily 30 minutes before bedtime.

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female
  • Aged 18-65
  • Experiencing issues with sleep (falling asleep, staying asleep)
  • Generally healthy
  • Willing to discontinue sleep-related supplements
  • Maintain consistent sleep patterns
  • Resides in the United States

You may not qualify if:

  • Chronic medical or sleep disorders
  • Use of sleep medications
  • Hormone therapy or anticoagulants
  • Heavy alcohol use
  • Night shift workers
  • Pregnancy or breastfeeding
  • Smoking or substance abuse
  • Allergies to ingredients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89118, United States

Location

MeSH Terms

Conditions

ParasomniasSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersSleep Disorders, IntrinsicDyssomnias

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 4, 2026

Study Start

November 3, 2024

Primary Completion

January 13, 2025

Study Completion

January 13, 2025

Last Updated

May 4, 2026

Record last verified: 2026-04

Locations